✅ Rob Fia, CEO of Therma Bright Said:
Toronto, Ontario--(Newsfile Corp. - January 20, 2022) - Therma Bright Inc. "We appreciate the patience of our clients, shareholders, and partners as they await the final results of our U.S Clinical Performance Study," shared Rob Fia, CEO of Therma Bright. "Our goal is to complete this study in January 2022 within the 300 participants range per our IRB Clinical Trials dashboard. ".